<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03248648</url>
  </required_header>
  <id_info>
    <org_study_id>IRB00008788</org_study_id>
    <nct_id>NCT03248648</nct_id>
  </id_info>
  <brief_title>Efficacy of Intra-articular Neostigmine Versus Ketamine for Postoperative Analgesia in Arthroscopic Knee Surgery</brief_title>
  <official_title>Efficacy of Intra-articular Neostigmine Versus Ketamine for Postoperative Analgesia in Arthroscopic Knee Surgery</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Assiut University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Ghada Mohammed AboelFadl</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Abualauon Elbiblawy</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Assiut University</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      To compare the efficacy of intra-articular administration of neostigmine versus ketamine as
      adjuvant analgesics after knee arthroscopy.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Arthroscopic knee surgery is commonly performed as an outpatient procedure and is often
      associated with postoperative pain. Intraarticular (IA) local anesthetics (LA) are often used
      for prevention of pain after arthroscopic knee surgery; however, the degree of postoperative
      pain varies. In an effort to find the ideal regime for sufficient, long-lasting postoperative
      analgesia, many different drugs, including opioids, nonsteroidal anti-inflammatory drugs,
      ketamine, clonidine, and neostigmine, have been added to the IA LAs The investigators
      designed this study to compare the efficacy of intra-articular administration of neostigmine
      versus ketamine as adjuvant analgesics after knee arthroscopy.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">March 1, 2017</start_date>
  <completion_date type="Anticipated">December 1, 2017</completion_date>
  <primary_completion_date type="Actual">September 1, 2017</primary_completion_date>
  <phase>Phase 2/Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
    <masking_description>Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor)</masking_description>
  </study_design_info>
  <primary_outcome>
    <measure>postoperative analgesic consumption</measure>
    <time_frame>36 hours postoperative the total consumption of analgesics in the first 36h postoperative</time_frame>
    <description>assessment of each patient on his bed at inpatient ward every 4 hours over a 36-hour period</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Postoperative visual analogue pain scale (VAS)</measure>
    <time_frame>36 hours postoperative</time_frame>
    <description>assessment of each patient on his bed at inpatient ward every 4 hours over a 36-hour period</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">100</enrollment>
  <condition>Postoperative Pain</condition>
  <arm_group>
    <arm_group_label>Neostigmine group</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>At the end of the surgery patients receive 0.5mg/dose neostigmine +18ml 0.25%bupivacaine in a total volume of 20 ml.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>ketamine group</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>At the end of the surgery patients receive 0.5 mg/kg ketamine+18ml 0.25%bupivacaine in a total volume of 20 ml.</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Neostigmine</intervention_name>
    <description>patient receive 0.5mg/dose neostigmine +18ml 0.25%bupivacaine in a total volume of 20 ml.</description>
    <arm_group_label>Neostigmine group</arm_group_label>
    <other_name>epistigmine</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>ketamine</intervention_name>
    <description>patient receive 0.5 mg/kg ketamine+18ml 0.25%bupivacaine in a total volume of 20 ml.</description>
    <arm_group_label>ketamine group</arm_group_label>
    <other_name>Ketalar</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  One hundred patients aged above 18-50 years (ASA I or II) scheduled for elective
             arthroscopic knee surgery under intrathecal anaesthesia will be enrolled in our study.

        Exclusion Criteria:

          -  Absolute or relative contraindications for intrathecal anaesthesia,

          -  Allergy for the studied drugs.

          -  Patients having history of cardiovascular, cerebrovascular, and respiratory diseases,

          -  Patients receiving chronic pain treatment or hypertension treated with α methyldopa,
             clonidine or β adrenergic blockers were excluded from the study.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>50 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Abualauon Elbiplaoy, lectural of anesthesia</last_name>
    <role>Principal Investigator</role>
    <affiliation>Assiut University</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Amany Hassan Abdel-Wahab, lectural of anesthesia</last_name>
    <phone>0100410623</phone>
    <email>Amanihassan1976@yahoo.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Ghada Mohamed Abu El fadl, lectural of anesthesia</last_name>
    <phone>01005802086</phone>
    <email>ghadafadl77@gmail.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Assiut university hospitals</name>
      <address>
        <city>Assiut</city>
        <state>Assiut governorate</state>
        <zip>Egypt, 715715</zip>
        <country>Egypt</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Amany Hassan Abdel-Wahab, lectural of anasthesia</last_name>
      <phone>01004610623</phone>
      <email>Amanihassan1976@yahoo.com</email>
    </contact>
    <contact_backup>
      <last_name>Ghada Mohamed Abu El fadl, lectural of anasthesia</last_name>
      <phone>01005802086</phone>
      <email>ghadafadl77@gmail.com</email>
    </contact_backup>
  </location>
  <location_countries>
    <country>Egypt</country>
  </location_countries>
  <verification_date>July 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>August 10, 2017</study_first_submitted>
  <study_first_submitted_qc>August 10, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">August 14, 2017</study_first_posted>
  <last_update_submitted>September 11, 2017</last_update_submitted>
  <last_update_submitted_qc>September 11, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">September 13, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Assiut University</investigator_affiliation>
    <investigator_full_name>Amani Hassan Abdel-Wahab</investigator_full_name>
    <investigator_title>MD</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Pain, Postoperative</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Bupivacaine</mesh_term>
    <mesh_term>Ketamine</mesh_term>
    <mesh_term>Neostigmine</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

